These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

To the extent it does matter though, the iShares S&P 500 Growth ETF is a better-balanced fund than comparable alternatives, ...

Icelandic biotechnology company Alvotech intends to explore the possibility of a Stockholm listing as it announced the acquisition of a Swedish research and development operation and drug candidate.

Looking for broad exposure to the Healthcare - Pharma segment of the equity market? You should consider the VanEck Pharmaceutical ETF (PPH), a passively managed exchange traded fund launched on ...

The Invesco Biotechnology & Genome ETF (PBE) made its debut on 06/23/2005, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market. What ...

Although LFSC launched just five months ago, the team at Emerald Advisers is highly experienced. Read why I don't recommend ...

Fisher Asset Management LLC raised its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 19.2% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,544 shares of the ...

US Bancorp DE lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 3.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 13,602 ...

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...